- Home
- Types & Treatments
- Bladder Cancer
- Diagnosis & Screening
Bladder Cancer
Bladder Cancer Screening and Diagnosis
Each year, more than 80,000 people in the U.S. receive a bladder cancer diagnosis. An estimated 70% of bladder cancer cases are nonmuscle invasive (typically less aggressive), while 30% of cases are more advanced. At this time, there is no accurate screening tool to detect bladder cancer.
At The University of Kansas Cancer Center, our urologic oncology surgeons use Blue Light Cystoscopy™ with Cysview® (BLC) to better diagnose, evaluate and remove bladder cancer tumors and lesions. As a result of positive outcomes in clinical trials, this technology is included in the bladder cancer guidelines published by the American Urological Association and the Society of Urologic Oncology.
Bladder Cancer Screening
Diagnostic tools we use to evaluate bladder tissue and deliver an accurate bladder cancer diagnosis may include:
Start your path today.
Your journey to health starts here. Call 913-588-1227 or request an appointment at The University of Kansas Cancer Center.